GoodRx Holdings, Inc. GDRX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other revenue | $17.06M-3.9% | $17.75M-3.6% | $18.41M-3.9% | $19.17M-4.2% | $20.01M-4.7% | |
| Prescription transactions revenue | $508.77M-6.5% | $544M-3.6% | $564.27M-2.3% | $577.39M-0.6% | $581.08M+0.6% | |
| Subscription revenue | $87.1M+4.0% | $83.73M+1.0% | $82.88M-0.7% | $83.46M-1.8% | $84.95M-1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does GoodRx Holdings, Inc. break its business down?
- GoodRx Holdings, Inc. (GDRX) reports revenue by product across 4 parts — Other revenue, Pharma Direct revenue, Prescription transactions revenue and Subscription revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does GoodRx Holdings, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in GoodRx Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
